Bill
H 859
An act relating to psychedelic therapy and clinical drug development trials
2025-2026 Regular Session
Introduced by Conor Casey and 5 co-sponsors
Vermont bill authorizing psychedelic-assisted therapy clinical trials to treat mental health conditions while navigating federal drug scheduling conflicts.
Read first time and referred to the Committee on Health Care